Purdue Pharma has filed for bankruptcy protection, in the wake of opposition to a global settlement resolution reported last week. The move is indicative of the privately-held company’s legal woes. Purdue, the maker of OxyContin, faces 2,600 lawsuits in a consolidated case set to be heard next month in Ohio.
Read more from Reuters here.